His current research is mainly focused on developing pipelines to discover informative biomarkers and building predictive tools to identify individuals who may be susceptible to severe adverse effects of chemotherapeutic drugs.
Research: Identifying biomarkers and developing predictive tools to help guide personalized therapy
Clinical Interests: Precision Oncology
